Brucella Melitensis: Identification and Characterization of Potential Drug Targets
Editat de Jangampalli Adi Pradeepkiran, S.B. Sainathen Limba Engleză Paperback – 24 feb 2021
In addition, the book demonstrates in silico approaches that offer insights into the identification of drug targets in B.melitensis 16M. The title employs a step-by-step approach to understanding drug targets by identifying and characterizing vaccine targets for Brucella melitensis, in silico screening, and the identification of novel drug targets from the total Brucella melitensis proteome. Other sections cover computational modeling and evaluation of the best potential drug targets through comparative modeling, molecular docking, and dynamics simulations of novel drug targets and in silico validation and ADMET analysis for best lead molecules.
- Covers the identification and characterization of vaccine targets for Brucella melitensis
- Presents in silico screening and the identification of novel drug targets
- Gives computational modeling and evaluations for potential drug targets
- Offers molecular docking and dynamics simulations for novel drug targets
- Details in silico validation and ADMET analysis for best lead molecules
Preț: 810.47 lei
Preț vechi: 1025.99 lei
-21% Nou
Puncte Express: 1216
Preț estimativ în valută:
155.11€ • 163.64$ • 129.26£
155.11€ • 163.64$ • 129.26£
Carte tipărită la comandă
Livrare economică 26 decembrie 24 - 09 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323856812
ISBN-10: 0323856810
Pagini: 200
Ilustrații: 25 illustrations (15 in full color)
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0323856810
Pagini: 200
Ilustrații: 25 illustrations (15 in full color)
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE
Cuprins
1. Introduction to Brucellosis 2. Identification and characterization of vaccine targets for Brucella melitensis through in silico approaches 3. Computational modeling and evaluation of best potential drug targets through comparative modeling 4. Molecular docking and dynamics simulations of novel drug targets 5. In silico validation and ADMET analysis for best lead molecules 6. Summary and Conclusions